牙周炎与COVID-19:生物学机制及流行病学证据的Meta分析
本文综述牙周炎与SARS-CoV-2感染及重症COVID-19关联的生物学机制与流行病学证据。牙周炎患者牙周组织中SARS-CoV-2主要受体与共受体(ACE2、TMPRSS2、furin、CD147)过表达。Meta分析显示牙周炎与SARS-CoV-2感染风险无统计学显著关联(OR=1.69;95%CI 0.91-3.13,P=0.09),但与住院(OR=4.72;95%CI 1.11-20.03,P=0.04)、需辅助通气(OR=6.24;95%CI 2.78-14.02,P=0.00)及死亡(OR=7.51;95%CI 2.16-26.10,P=0.00)风险升高相关。
要点
- 牙周炎患者牙周组织中ACE2、TMPRSS2、furin、CD147过表达。
- 牙周炎与SARS-CoV-2感染风险无统计学显著关联(OR=1.69;95%CI 0.91-3.13,P=0.09)。
- 牙周炎与COVID-19住院、辅助通气及死亡风险升高相关。
核心结论
- Meta分析提示牙周炎与SARS-CoV-2感染风险无统计学显著关联,但与更严重COVID-19病程相关。
- 牙周炎与住院、需辅助通气及死亡风险升高相关,强调口-全身联系作为缓解COVID-19紧急状态及未来冠状病毒大流行目标的 relevance。
研究设计与样本
- 本文为叙述性综述与Meta分析,批判性评价牙周炎与SARS-CoV-2感染及重症COVID-19关联的生物学机制与流行病学证据。
主要发现
- 牙周炎患者牙周组织中SARS-CoV-2主要受体与共受体(ACE2、TMPRSS2、furin、CD147)过表达,炎症、牙周病原体及损伤诱导的焦亡触发正反馈环路。
- Meta分析显示牙周炎与SARS-CoV-2感染风险无统计学显著关联(OR=1.69;95%CI 0.91-3.13,P=0.09)。
- 牙周炎与住院风险升高相关(OR=4.72;95%CI 1.11-20.03,P=0.04)。
- 牙周炎与需辅助通气风险升高相关(OR=6.24;95%CI 2.78-14.02,P=0.00)。
- 牙周炎与COVID-19并发症死亡风险升高相关(OR=7.51;95%CI 2.16-26.10,P=0.00)。
关键数值与推荐
- 牙周炎 vs 无牙周炎:SARS-CoV-2感染风险 OR=1.69(95%CI 0.91-3.13,P=0.09),未达统计学显著。
- 牙周炎 vs 无牙周炎:住院风险 OR=4.72(95%CI 1.11-20.03,P=0.04)。
- 牙周炎 vs 无牙周炎:需辅助通气风险 OR=6.24(95%CI 2.78-14.02,P=0.00)。
- 牙周炎 vs 无牙周炎:COVID-19并发症死亡风险 OR=7.51(95%CI 2.16-26.10,P=0.00)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Since the beginning of 2020, the entire global health care system has been severely challenged by the outbreak of coronavirus 2019 disease (COVID-19). Robust evidence has demonstrated a more severe course of COVID-19 in the presence of several comorbidities, such as cardiovascular diseases, diabetes mellitus, and obesity. Here, we critically appraise the recent research discoveries linking periodontitis to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and to severe COVID-19, with a special focus on the associated biological mechanisms and the available epidemiological evidence. SARS-CoV-2 main receptors and coreceptors (ACE2, TMPRSS2, furin, CD147) are overexpressed in periodontal tissues of periodontitis patients, with inflammation, periodontal pathogens, and damage-induced pyroptosis triggering a positive feedback loop. However, meta-analyses of epidemiological studies only indicated a nonstatistically significant tendency for an increased risk of SARS-CoV-2 infection in subjects with periodontitis (odds ratio [OR] = 1.69; 95% CI, 0.91-3.13, P = 0.09). Furthermore, periodontitis may worsen clinical COVID-19 courses through multiple direct and indirect pathways, including damage to lower airways due to aspiration of periodontal pathogens, exacerbation of the cytokine storm via the low-grade chronic systemic inflammation, and SARS-CoV-2 dissemination through the ulcerated gingival epithelium with consequent induced pulmonary vessels vasculopathy. Indeed, meta-analyses of epidemiological studies indicated that periodontitis subjects are more likely to experience a more severe course of COVID-19. Specifically, periodontitis was associated with a 4-fold increased odds of hospitalization (OR = 4.72; 95% CI, 1.11-20.03, P = 0.04), 6-fold of requiring assisted ventilation (OR = 6.24; 95% CI, 2.78-14.02, P = 0.00), and more than 7-fold of death due to COVID-19 complications (OR = 7.51; 95% CI, 2.16-26.10, P = 0.00). The breakthrough analyzed here emphasizes the relevance of the mouth-systemic connection as a target to mitigate the current COVID-19 emergency and the future predicted coronavirus pandemics.
引用
- Baima G, Marruganti C, Sanz M, et al. Periodontitis and COVID-19: Biological Mechanisms and Meta-analyses of Epidemiological Evidence. J Dent Res. 2022. PMID: 35774019. doi:10.1177/00220345221104725
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。